Cleo Diagnostics (ASX:COV) Other Long Term Assets : A$0.00 Mil (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Cleo Diagnostics Other Long Term Assets?

Cleo Diagnostics's other long-term assets for the quarter that ended in Dec. 2023 was A$0.00 Mil.

Cleo Diagnostics's quarterly other long-term assets increased from Dec. 2022 (A$-0.00 Mil) to Jun. 2023 (A$0.00 Mil) and increased from Jun. 2023 (A$0.00 Mil) to Dec. 2023 (A$0.00 Mil).

Cleo Diagnostics's annual other long-term assets stayed the same from . 20 (A$0.00 Mil) to . 20 (A$0.00 Mil) but then increased from . 20 (A$0.00 Mil) to Jun. 2023 (A$0.00 Mil).

Cleo Diagnostics Other Long Term Assets Historical Data

The historical data trend for Cleo Diagnostics's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cleo Diagnostics Other Long Term Assets Chart

Cleo Diagnostics Annual Data

Trend

Jun23

Other Long Term Assets

Cleo Diagnostics Semi-Annual Data
	Dec22	Jun23	Dec23
Other Long Term Assets	-	-	-

Cleo Diagnostics Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Cleo Diagnostics (ASX:COV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cleo Diagnostics Ltd (ASX:COV) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

480 Collins Street, Level 2, Melbourne, VIC, AUS, 3000

Website

https://www.cleodx.com

Cleo Diagnostics Ltd is focused on the development of non-invasive blood-based IVD tests to detect the presence, and recurrence, of ovarian cancer. The Company's first product to market is intended to be the Triage Test which has to date produced strong results to accurately differentiate patients with malignant ovarian cancer from those with benign gynaecological conditions. The Company aims to improve the diagnostic process and procedures for detecting ovarian cancer and, in this regard, improve quality-of-life outcomes for patients who have been diagnosed with ovarian cancer.

Cleo Diagnostics (ASX:COV) Headlines

No Headlines